COVID-19

This marks the fourth drug, and first oral antiviral pill, approved by the FDA to treat adults with mild-to-moderate COVID-19.

EUA restriction for hospitalized patients was basis for lawsuit that advanced several arguments.

Reporting vaccination data to Immunization Information Systems databases can support public health surveillance activities.

The risk of long COVID-19 in females in the least deprived areas was comparable to the risk of males in the most deprived areas.

Many patients with post-COVID-19 condition reported perceived cognitive deficits early during their COVID-19 infection as well.

Federal legislation addresses variety of issues and seeks to build on gains made under the Affordable Care Act.

Study evaluates the effect of long-acting monoclonal antibodies tixagevimab and cilgavimab treating COVID-19 symptoms and viral shedding.

Investigators of the phase 2 study also found a comparable reactogenicity to the individual influenza and COVID-19 vaccines from Novavax or authorized vaccine comparators.

Study shows that the nervous system of individuals experiencing post-COVID-19 fatigue is underactive in 3 key areas.

Investigators found that providing parents with a hypothetical scenario outlining why they should immunize their children against COVID-19 was effective in improving vaccination rates.

The 2022-2023 COVID-19 season did not have a significant surge of COVID-19 like it did early on in the COVID-19 pandemic.

Data from the expanded trial suggests that the NVX-CoV2373 COVID-19 vaccine protects against multiple viral variants.

Neutralizing monoclonal antibody therapies found to improve outcomes for unvaccinated and nonhospital patients at high risk of poor outcome for SARS-CoV-2.

The BCG vaccine was more likely to cause symptomatic or severe COVID-19 in patients that had a preexisting condition, such as heart disease, by 6 months.

Study shows intramuscular injection may improve treatment success by increasing the speed of drug absorption.

Analysis shows that the ratio of neutralizing antibody geometric mean titers in adolescents compared with young adults was 1.5 after vaccination with NVX-CoV2373.

Risk of incident diabetes was markedly higher among males and in those with more severe COVID-19.

The SUNRISE-3 trial is investigating its use in high-risk patients regardless of COVID-19 vaccination status.

Study results indicate a decrease in the exclusion of older adults but no significant change for individuals who are immunocompromised.

All-cause inpatient mortality or discharge to hospice was lower for patients who received dexamethasone within 48 hours of either admission or escalation in oxygen support.

Results of a review show that lessons learned from the pandemic apply to the respiratory syncytial virus.

Worldwide, the human immune system tends to make the same antibodies when targeting viruses, which can modify their structure to avoid detection.

Agency updates emergency use authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccinations, which are no longer authorized for used in the United States.

The data support the use of interventions at home, including frequent handwashing, physical distancing, regular surface disinfection, and wearing a mask.

Emerging evidence suggests that the risk of maternal mortality was more than 10-times greater among those with COVID-19 infection.